Immunologic suppression by methotrexate in dermatology.
D000328:Adult; D002986:Clinical Trials as Topic; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular / Q000187:drug effects*; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000209:etiology; D010392:Pemphigus / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D012882:Skin Tests
D008727:Methotrexate